| CTRI Number |
CTRI/2024/11/076984 [Registered on: 19/11/2024] Trial Registered Prospectively |
| Last Modified On: |
29/10/2024 |
| Post Graduate Thesis |
No |
| Type of Trial |
Observational |
|
Type of Study
|
Cohort Study |
| Study Design |
Other |
|
Public Title of Study
|
Interface between Late Life Depression and Dementia |
|
Scientific Title of Study
|
Assessing the role of neuroimaging connectomes and neuropsychological profiles in predicting cognitive decline in late-life depression: A prospective study |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Shalini Perugu |
| Designation |
Assistant Professor |
| Affiliation |
St.Johns Medical College |
| Address |
Department of Psychiatry
St.Johns Medical College Hospital
Bangalore
Bangalore KARNATAKA 560034 India |
| Phone |
7338539222 |
| Fax |
|
| Email |
shalini.p@stjohns.in |
|
Details of Contact Person Scientific Query
|
| Name |
Shalini Perugu |
| Designation |
Assistant Professor |
| Affiliation |
St.Johns Medical College |
| Address |
Department of Psychiatry
St.Johns Medical College Hospital
Bangalore
Bangalore KARNATAKA 560034 India |
| Phone |
7338539222 |
| Fax |
|
| Email |
shalini.p@stjohns.in |
|
Details of Contact Person Public Query
|
| Name |
Shalini Perugu |
| Designation |
Assistant Professor |
| Affiliation |
St.Johns Medical College |
| Address |
Department of Psychiatry
St.Johns Medical College Hospital
Bangalore
Bangalore KARNATAKA 560034 India |
| Phone |
7338539222 |
| Fax |
|
| Email |
shalini.p@stjohns.in |
|
|
Source of Monetary or Material Support
|
|
|
Primary Sponsor
|
| Name |
ICMR DHR Young Medical Faculty Ph.D. program 2024 |
| Address |
V. Ramalingaswami Bhawan, P.O. Box No. 4911, Ansari Nagar, New Delhi - 110029, India |
| Type of Sponsor |
Government funding agency |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Shalini Perugu |
St.Johns Medical College Hospital |
Room no 25, Psychiatry OPD
Sarjapura road
Koramangala
Bangalore 560034 Bangalore KARNATAKA |
08022065570
shalini.p@stjohns.in |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| St.Johns Medical College Hospital Institutional Ethics Committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Healthy Human Volunteers |
Screening |
| Patients |
(1) ICD-10 Condition: F028||Dementia in other diseases classified elsewhere, (2) ICD-10 Condition: F334||Major depressive disorder, recurrent, in remission, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
NIL |
NIL |
| Comparator Agent |
NIL |
NIL |
|
|
Inclusion Criteria
|
| Age From |
60.00 Year(s) |
| Age To |
99.00 Year(s) |
| Gender |
Both |
| Details |
Group with Late life Depression- Persons meeting criteria for Major depressive disorder according to DSM 5 diagnostic guidelines
Group with Dementia-Persons meeting criteria for Major neurocognitive disorder of mild severity according to DSM 5 diagnostic guidelines
Group with Healthy volunteers- Persons without a diagnosis of Major depressive disorder and Major neurocognitive disorder |
|
| ExclusionCriteria |
| Details |
Group with Late life Depression-Persons with diagnosis of a preexisting psychiatric or neurological illness
Group with Dementia-Persons with diagnosis of Major cognitive disorder due to Traumatic brain injury, Infective/Substance related etiology and those with early onset dementia
Group with Healthy volunteers-Persons with diagnosis of a preexisting psychiatric or neurological illness |
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Cognitive Decline |
Intake and 1 year follow up |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Neuroimaging connectome |
Baseline |
|
|
Target Sample Size
|
Total Sample Size="150" Sample Size from India="150"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
01/01/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="5" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Summary Background: Dementia is a syndrome typically caused by progressive cognitive decline in neurodegenerative diseases resulting in impairment of activities of daily living. There is a substantial economic burden at family and community level. The Longitudinal Aging Study in India (LASI) estimated dementia prevalence for adults ages 60+ in India is 7.4%. A systematic review and meta-analysis estimated the pooled prevalence of depression among the elderly population in India to be approximately 34.4%. The 2020 Lancet commission on Dementia lists 12 modifiable risk factors that together account for 40% of dementias worldwide and theoretically they could be prevented or delayed. LLD accounts for 4% of the risk. Late-life depression is associated with cognitive impairments that may persist even after successful treatment of depressive symptoms, potentially serving as an early indicator or prodrome of dementia. LLD is considered both a risk factor and prodrome of Dementia, but the link between LLD and Dementia has not been fully elucidated. Not all patients with LLD progress into Dementia. While there is a well-established association between late-life depression and increased dementia risk, the causal pathways remain unclear. It is not clear as to which clinical and neuropsychological profile of patients develop Dementia. Dementia and late-life depression LLD both involve significant alterations in brain networks, which are linked to their symptoms and progression. Neuroimaging offers several advantages as a biomarker for dementia. Human Connectome Project (HCP), Alzheimer’s Disease Neuroimaging Initiative (ADNI) and Alzheimer’s Disease Connectome Project (ADCP) are ongoing connectome based projects looking at neuroimaging as a biomarker for AD. To the best of our knowledge, non of the studies looked at comparing connectomes of LLD which is considered a risk factor/prodrome with that of Dementia. In this study we intend to fill this gap thereby facilitating early diagnosis and treatment initiation for Dementia. Novelty: To build neuroimaging connectome datasets for Late Life Depression (LLD), Dementia and healthy controls for our population. Many studies have looked at neuropsychological profiles and single MRI sequence to explore the correlation between LLD and Dementia. This study looks at multimodal imaging which will allow us to build a predictive model for cognitive decline in LLD with more accuracy. To the best of our knowledge this is the first study from India exploring the connection between LLD and Dementia through multimodal imaging. Methods and procedure: A prospective study of persons with LLD(n=35) with comparison groups of Dementia(n=35) and healthy controls(n=35). Connectomes are built using multimodal neuroimaging ( T1,T2,FLAIR,DWI,DTI,ASL and rsfMRI) sequences and neuropsychological assessments are carried out at 6 month and 12 month time points. A predictive model for cognitive decline in LLD will be built using the neuroimaging, neuropsychological and clinical data. Outcome: Datasets for LLD, Dementia and healthy population. A predictive model that’ll inform us about which LLD patients are more likely to develop cognitive decline. This helps in early diagnosis and treatment planning Dementia. Having these datasets for our population will nurture future research in the field. Keywords: Late Life Depression, Dementia, Connectome, Datasets, Predictive model Problem Statement LLD is considered both a risk factor and prodrome of Dementia, but the link between LLD and Dementia has not been fully elucidated. Not all patients with LLD progress into Dementia. It is not clear as to which clinical and neuropsychological profile of patients develop Dementia. Though many prospective studies have established the temporal association of LLD and Dementia, the known biomarkers didn’t yield conclusive evidence for the same. Neuroimaging findings are one of the biomarkers that will inform us about the risk of progression to Dementia. Till now many prospective studies have looked at individual sequences and techniques of neuroimaging to establish a link between LLD and Dementia and identified patterns similar to both the conditions. But there is lot of inconsistency due to multiple factors like symptom heterogeneity, lack of experimental rigor, individual marker/ imaging technique etc. Use of multimodal neuroimaging techniques, each having its own strengths yields more comprehensive understanding of brain abnormalities, pathology, and their relationship to clinical symptoms. Hypothesis/ Research question: This study hypothesizes that Late life depression (LLD) and Dementia share more underlying structural and functional changes in the brain than previously understood. We intend to investigate this overlap by creating connectomes using advanced neuroimaging techniques and study specific patterns of connectome that will predict the cognitive decline in LLD patients. The research question: How do neuroimaging connectomes in LDD and Dementia patients overlap and differ and can specific connectome patterns in LLD patients predict the extent of cognitive decline at one year follow-up? |